SHIP1 modulation and proteome characterization of microglia
Journal of Proteomics · 2024
DOI: 10.1016/j.jprot.2024.105198 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Proteomics, 2024. Verfasst von Erpan Ahat und 11 weiteren Autor:innen. Beteiligte Einrichtung: Eli Lilly and Company, Indianapolis, USA. Electronic address: ahat_erpan@lilly.com. Hauptthemen laut MEDLINE: Microglia, Phosphatidylinositol-3,4,5-Trisphosphate 5-Phosphatases, Proteome, Alzheimer Disease. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIA NIH HHS, National Institutes of Health.
Abstract (Originalsprache)
Understanding microglial states in the aging brain has become crucial, especially with the discovery of numerous Alzheimer's disease (AD) risk and protective variants in genes such as INPP5D and TREM2, which are essential to microglia function in AD. Here we present a thorough examination of microglia-like cells and primary mouse microglia at the proteome and transcriptome levels to illuminate the roles these genes and the proteins they encode play in various cell states. First, we compared the proteome profiles of wildtype and INPP5D (SHIP1) knockout primary microglia. Our findings revealed significant proteome alterations only in the homozygous SHIP1 knockout, revealing its impact on the microglial proteome. Additionally, we compared the proteome and transcriptome profiles of commonly used in vitro microglia BV2 and HMC3 cells with primary mouse microglia. Our results demonstrated a substantial similarity between the proteome of BV2 and mouse primary cells, while notable differences were observed between BV2 and human HMC3. Lastly, we conducted targeted lipidomic analysis to quantify different phosphatidylinositols (PIs) species, which are direct SHIP1 targets, in the HMC3 and BV2 cells. This in-depth omics analysis of both mouse and human microglia enhances our systematic understanding of these microglia models. SIGNIFICANCE: Given the growing urgency of comprehending microglial function in the context of neurodegenerative diseases and the substantial therapeutic implications associated with SHIP1 modulation, we firmly believe that our study, through a rigorous and comprehensive proteomics, transcriptomics and targeted lipidomic analysis of microglia, contributes to the systematic understanding of microglial function in the context of neurodegenerative diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Eli Lilly and Company, Indianapolis, USA. Electronic address: ahat_erpan@lilly.com.
- Department of Biostatistics & Health Data Science, Indiana University School of Medicine, Indianapolis, USA.
- Department of Medicine, Division of Clinical Pharmacology, Indiana University School of Medicine, Indianapolis, USA.
- Eli Lilly and Company, Indianapolis, USA.
- Stark Neurosciences Research Institute, Indiana University School of Medicine, Indianapolis, IN 46202, USA.
- Department of Radiology & Imaging Sciences, Indiana University School of Medicine, Indianapolis, USA; Stark Neurosciences Research Institute, Indiana University School of Medicine, Indianapolis, IN 46202, USA.
Förderung
- NIA NIH HHS
- National Institutes of Health
Zitieren
APA
Ahat, E., Shi, Z., Chu, S., Bui, H. H., Mason, E. R., Soni, D. M., Roth, K. D., Chalmers, M. J., Oblak, A. L., Zhang, J., Gutierrez, J. A., & Richardson, T. (2024). SHIP1 modulation and proteome characterization of microglia. Journal of Proteomics. https://doi.org/10.1016/j.jprot.2024.105198
Vancouver
Ahat E, Shi Z, Chu S, Bui HH, Mason ER, Soni DM, et al. SHIP1 modulation and proteome characterization of microglia. Journal of Proteomics. 2024. doi:10.1016/j.jprot.2024.105198
BibTeX
@article{Ahat2024,
author = {Ahat, Erpan and Shi, Zanyu and Chu, Shaoyou and Bui, Hai Hoang and Mason, Emily R and Soni, Disha M and Roth, Kenneth D and Chalmers, Michael James and Oblak, Adrian L and Zhang, Jie and Gutierrez, Jesus A and Richardson, Timothy},
title = {SHIP1 modulation and proteome characterization of microglia},
journal = {Journal of Proteomics},
year = {2024},
doi = {10.1016/j.jprot.2024.105198}
}
EUVIMED